Xianjue Ma

1.1k citations
44 papers · 823 indexed · h-index 16
Topics
Hippo pathway signaling and YAP/TAZ (27 papers)Ubiquitin and proteasome pathways (9 papers)Wnt/β-catenin signaling in development and cancer (7 papers)

In The Last Decade

Xianjue Ma

41 papers receiving 821 citations

Peers

Xianjue Ma
Comparison fields: 5 of 88
  • Molecular Biology 463
  • Cell Biology 331
  • Cellular and Molecular Neuroscience 168
  • Immunology 136
  • Pharmacology 133
Replace Konstantin Glebov with:
Konstantin Glebov Germany
Haeryun Lee United States
Ying Y. Jean United States
Sujata Bupp United States
Νικόλαος Γιαγτζόγλου United States
Sabine Traver France
Yonatan Perez Israel
Mahdi Ghani Canada
Jim Dompierre France
Thorsten Fritzius Switzerland
Xianjue Ma relative to Konstantin Glebov Germany Konstantin Glebov's profile →
Citations per field
00.5×3.3×
Konstantin Glebov · 1×
Citations per year

Countries citing papers authored by Xianjue Ma

Since Specialization
Citations

This map shows the geographic impact of Xianjue Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianjue Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianjue Ma more than expected).

Fields of papers citing papers by Xianjue Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianjue Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianjue Ma. The network helps show where Xianjue Ma may publish in the future.

Co-authorship network of co-authors of Xianjue Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xianjue Ma. A scholar is included among the top collaborators of Xianjue Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianjue Ma. Xianjue Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 9
4 2
5 7
6 11
7 16
8 18
9 5
10 8
11 4
12 29
13 42
14 2
15 26
16 52
17 47
18 52
19 1
20 9

About Xianjue Ma

Xianjue Ma is a scholar working on Aging, Cell Biology and Molecular Biology, having authored 44 papers that have together received 823 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (27 papers), Ubiquitin and proteasome pathways (9 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). The work is most often cited by research in Biological Psychiatry (110 citations), Cell Biology (331 citations) and Aging (23 citations). Xianjue Ma has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lei Xue, Wenzhe Li, Wenyan Xu, Lei Xue, Tian Xu, Monique Thomas, Kevin L. Behar, Golam M. I. Chowdhury, Gerard Sanacora and Eric Schaeffer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026